Carnegie Investment Counsel’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$349K Sell
722
-75,397
-99% -$20M 0.01% 458
2026
Q1
$8.34M Buy
76,119
+15,710
+26% +$2.24M 0.16% 145
2025
Q4
$10M Buy
+60,409
New +$10.1M 0.19% 138

Other funds holding ALAB

Carnegie Investment Counsel's ALAB Position: Q2 2026 in Review

Carnegie Investment Counsel reduced its Astera Labs (ALAB) stake by 99% in Q2 2026, selling an estimated $20M and leaving 722 shares worth $349K. The position accounts for 0.01% of the portfolio, ranked #458.

Carnegie Investment Counsel first reported a position in ALAB in Q4 2025 and has held it in 3 quarters since. The position peaked at $10M in Q4 2025. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Carnegie Investment Counsel held 722 shares of Astera Labs worth $349K as of Q2 2026.
  • Carnegie Investment Counsel sold 75,397 Astera Labs shares in Q2 2026, an estimated $20M.
  • Astera Labs made up 0.01% of Carnegie Investment Counsel's portfolio in Q2 2026, its #458 holding.
  • Carnegie Investment Counsel first reported a position in Astera Labs in Q4 2025 and has held it in 3 quarters since.
  • Carnegie Investment Counsel's Astera Labs position peaked at $10M in Q4 2025.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Carnegie Investment Counsel's 13F filing for Q2 2026, filed 30 Jul 2026.